MB
Moonwalk Biosciences, Inc.
SEC filingBiotechnology · South San Francisco, CA
Amount raised$60Msold at filing
Total offering$70.2M$10.2M still open
Investors in the raise7count reported to the SEC
FiledSep 14, 2026first sale Aug 26, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
John LilesExecutive Officer
Chris DimitropoulosDirector
Arash JamshidiExecutive Officer, Director
Alexander AravanisExecutive Officer, Director
Justin ValleyExecutive Officer
Stephen DjedjosExecutive Officer
Paul BurtonDirector
Elaine CheungExecutive Officer
Executive officers, directors and promoters as listed on the Form D.